Neurotranq tabletten, 10 mg voor honden en katten
Neurotranq tabletten, 10 mg voor honden en katten
Not authorised
- Acepromazine
Product identification
Medicine name:
Neurotranq tabletten, 10 mg voor honden en katten
Active substance:
- Acepromazine
Target species:
-
Dog
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Acepromazine10.00/milligram(s)1.00Piece
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
-
Dog
-
Cat
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN05AA04
Legal status of supply:
-
Medicinal product subject to medical prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Netherlands
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Alfasan Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Alfasan Nederland B.V.
Responsible authority:
- Medicines Evaluation Board
Authorisation number:
- REG NL 2122
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Dutch (PDF)
Published on: 14/02/2022
How useful was this page?:
